Triangle Insights Group is a strategy consulting firm that provides strategic guidance on the most critical business issues to leaders in life sciences organizations. The company supports clients in the therapeutics, diagnostics, and medical device industries and has partnered with clients to address needs across the pharmaceutical development and commercial lifecycle. The firm was acquired in 2022 by TrialCard, a full-service life sciences commercialization company.

Triangle's approach combines deep knowledge of the industry across therapeutic areas and functional domains. The organization provides its clients with the experience to adeptly understand strategic issues, creativity to identify solutions, strong critical thinking to evaluate options, and the discipline to drive results. The partners are experienced management consultants whose backgrounds include Boston Consulting Group (BCG), Syneos Health, Oliver Wyman, and L.E.K. Consulting. In addition to guidance on project activities, the partners make themselves regularly available to all staff for mentorship and coaching opportunities.